Joseph Thome, Ph.D.

Managing Director, Health Care - Biotechnology

Joseph Thome, Vice President, Health Care - Biotechnology

Joseph Thome is a managing director and senior research analyst on Cowen and Company’s biotechnology team. Dr. Thome was selected as a “Rising Star in Equity Research” by Business Insider in 2021 and the Cowen biotechnology team has consistently been among the top-ranked teams in the Greenwich Survey.

Prior to joining Cowen in March 2016, Dr. Thome was an NIH pre-doctoral research fellow at Columbia University, studying the compartmentalization and maintenance of the human T cell immune response from infancy into adulthood. His research has been published in several prestigious journals including Cell and Nature Medicine.

Dr. Thome received a BA with high honors in chemistry and biochemistry from Oberlin College and a Ph.D. in microbiology and immunology from Columbia University, where he was granted the Dean’s Award for Excellence in Research. HCBiopharma

Get In Touch

Start a conversation with Joseph Thome


Explore related thought leadership, reports, coverage and insights for Joseph Thome.


ESG Best Ideas 2022

Read More
Ahead of the Curve®

Trials and Triumphs of Gene Editing: A Compendium

Read More
Ahead of the Curve®

An Investor’s Guide to Bispecific Antibodies

Read More

Research Contacts

Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

Meet Our People
Senior businessman handshaking with young woman in the office